About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-ND1
A3395G
A3395G-F4
A3395G-F2
A3399T
A3995G
A3995G-F1
A4136G
C3340T
C3497T
C3497T-F1
C3571T
C3571T-F1
C3761A
C4171A
C4171A-F3
C4171A-F2
C4171A-F1
G3316A
G3376A
G3376A-F1
G3380A
G3421A
G3421A-F1
G3437A
G3460A
G3460A-F22
G3460A-F19
G3460A-F18
G3460A-F17
G3460A-F16
G3460A-F15
G3460A-F14
G3460A-F13
G3460A-F12
G3460A-F11
G3460A-F10
G3460A-F5
G3460A-F2
G3460A-F1
G3481A
G3481A-F1
G3635A
G3635A-F17
G3635A-F16
G3635A-F15
G3635A-F14
G3635A-F13
G3635A-F12
G3635A-F11
G3635A-F10
G3635A-F9
G3635A-F8
G3635A-F7
G3635A-F5
G3635A-F4
G3635A-F2
G3635A-F1
G3688A
G3697A
G3697A-F5
G3697A-F4
G3697A-F3
G3700A
G3733A
G3733A-F2
G3733A-F1
G3890A
G3890A-F5
G3890A-F4
G3946A
G3955A
G3955A-F2
G3955A-F1
G4132A
G4132A-F1
G4142A
G4175A
T3308C
T3365C
T3394C
T3394C-F9
T3394C-F8
T3394C-F7
T3394C-F6
T3394C-F5
T3394C-F4
T3394C-F3
T3394C-F2
T3394C-F1
T3396C
T3396C-F1
T3398C
T3472C
T3472C-F2
T3472C-F1
T3667G
T3833A
T3949C
T4135C
T4160C
T4160C-F3
T4160C-F1
T3685C
Edit by Mitofam Team
-
+
首页
G3380A
# **General Information** | **Position** | **3380** | **Variant** | **m.3380G\>A** | **Locus** | **MT\-ND1** | **Amino\-AcidChange** | **R25Q** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **APOGEE2** | Likely\-pathogenic | **Pathogenicity** | Reported \[VUS] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.3380G\>A** variant in MT\-ND1 has been reported in 1 pedigree. To date, 4 carriers have been reported. Reported mutation loads ranged from 0% to 50%, with a median of 0% overall; affected carriers showed mutation loads from 7% to 50%, with a median of 28\.5%; unaffected carriers showed mutation loads from 0%, with a median of 0%. In one affected carrier, a marked tissue\-specific difference was observed, with higher mutation loads in muscle (50%) than in blood (7%). The main clinical manifestations among affected carriers included MELAS. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 3380 | m.3380G\>A | G3380A\-F1 | Germany | MELAS Bilateral sensorineural hearing lossStatus epilepticusStroke\-like episodesCortical blindnessGlobal aphasiaHemiparesisHemianopiaAtaxiaPallhypesthesiaNon\-vascular cortical lesions on MRI | ND | ND | 2008 | [18590963](https://pubmed.ncbi.nlm.nih.gov/18590963/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 3380 | m.3380G\>A | G3380A\-F1 | G3380A\-F1\-II2 | Uninf | F | Y | Y | A | 62 | 7% | 50% | / | / | MELAS | | | 2 | 3380 | m.3380G\>A | G3380A\-F1 | G3380A\-F1\-III1 | Uninf | M | N | N | A | 34 | 0 | / | / | / | healthy | | | 3 | 3380 | m.3380G\>A | G3380A\-F1 | G3380A\-F1\-III2 | Uninf | M | N | N | A | 31 | 0 | / | / | / | healthy | | | 4 | 3380 | m.3380G\>A | G3380A\-F1 | G3380A\-F1\-III3 | Uninf | M | N | N | A | 27 | 0 | / | / | / | healthy | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月30日 03:19
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)